BXMIX
Price
$10.82
Change
+$0.01 (+0.09%)
Updated
May 23 closing price
Net Assets
3.7B
GMCMX
Price
$10.49
Change
+$0.05 (+0.48%)
Updated
May 23 closing price
Net Assets
58.11M
Interact to see
Advertisement

BXMIX vs GMCMX

Header iconBXMIX vs GMCMX Comparison
Open Charts BXMIX vs GMCMXBanner chart's image
Blackstone Alternative Multi-Strategy I
Price$10.82
Change+$0.01 (+0.09%)
VolumeN/A
Net Assets3.7B
Goldman Sachs Multi-Strategy Alts C
Price$10.49
Change+$0.05 (+0.48%)
VolumeN/A
Net Assets58.11M
BXMIX vs GMCMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BXMIX vs. GMCMX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BXMIX is a Hold and GMCMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BXMIX has more cash in the bank: 3.7B vs. GMCMX (58.1M). BXMIX pays higher dividends than GMCMX: BXMIX (5.71) vs GMCMX (3.07). BXMIX was incepted earlier than GMCMX: BXMIX (11 years) vs GMCMX (12 years). BXMIX (5.22) is less costly to investors than GMCMX (2.71). GMCMX has a lower initial minimum investment than BXMIX: GMCMX (1000) vs BXMIX (100000). GMCMX annual gain was more profitable for investors over the last year : 9.07 vs. BXMIX (4.02). BXMIX return over 5 years is better than : 29.29 vs. GMCMX (7.99).
BXMIXGMCMXBXMIX / GMCMX
Total Expense Ratio5.221.90275%
Annual Report Gross Expense Ratio5.222.71193%
Fund Existence11 years12 years-
Gain YTD1.0276.60616%
Front LoadN/AN/A-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.7B58.1M6,361%
Annual Yield % from dividends5.713.07186%
Returns for 1 year4.029.0744%
Returns for 3 years16.590.961,719%
Returns for 5 years29.297.99367%
Returns for 10 years22.620.564,064%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPCX12.65N/A
N/A
Saratoga Health & Biotechnology C
STSOX31.24N/A
N/A
Sterling Capital SmCp Val C
BGRUX90.18N/A
N/A
Baron Growth R6
BMSRX13.84N/A
N/A
MFS Blended Research Mid Cap Eq R1
WINIX10.37N/A
N/A
Wilmington International Institutional